Skip to main content
Equibles

MANKIND · Mankind Pharma Limited · Documents

Use MANKIND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MANKIND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,638.60 INR -21.40 (-0.80%) At close · Nov 12
Rebalance outlook locked
Market Cap
1.09T INR
Shares
413.05M
Volume · Nov 12 424.11K Avg daily vol (3M) 567.51K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 26, 2026
2026
Oct 26
Earnings call
Q2 2027 earnings call

Mankind Pharma’s Q2 FY27 revenue was Rs. 4,338 crores, up 17.3% year-on-year; PAT reached Rs. 716 crores and EBITDA margin was 27.1%. International revenue grew 33% to Rs. 680 crores, while net debt was Rs. 2,639 crores.

Showing 1–3 of 3 documents